Conference Description:

Clinical trials are the engine of medical progress—driving new treatments, improving outcomes, and advancing scientific knowledge. Their success depends on collaboration, innovation, and strategic execution at every step.

Now in its 17th year, SCOPE returns February 2–5, 2026, to Rosen Shingle Creek in Orlando, FL, bringing together the full clinical research ecosystem for four high-impact days of discussion, strategy, and networking.

SCOPE 2025 convened 4,500+ attendees (10% growth over 2024), 630 speakers, and 300 exhibitors (20% growth over 2024), with 60% in key decision-making roles, cementing its position as the premier event for clinical trial innovation. In 2026, we’re building on that momentum with:

30 conference tracks (including 3 new additions, Market Access, Safety, Therapeutic Area Spotlights) and 3 plenary keynotes
A bustling exhibit hall with 300+ companies (up 45 from last year)
The 10th annual Participant Engagement Award and 3rd annual Site Innovation Award
The Best of Show Awards, cross-functional panels, and multiple networking receptions
The 5th annual Master of Clinical Research Golf Tournament and a morning Fun Run
Our 2026 program expands coverage of in-demand topics like Development Planning, Protocol Optimization, Patient-Centric Trial Design, Site Engagement & Recruitment, Generative AI, Small Biopharma Strategies, RBQM, Supply and ClinTech Investment—all focused on advancing solutions in trial planning, operations, innovation, and investment.

SCOPE Summit welcomes senior executives from pharma, biotech, CROs, sites, technology, investment, and patient advocacy organizations, representing over 1,200 companies across 30 countries. If you’re shaping the future of clinical research, you belong at SCOPE.